(Q33714847)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Gokhan Gulkilik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Muhittin Taskapili

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Selim Kocabora

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Gulipek Muftuoglu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

10 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

International Ophthalmology

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

697-702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20936526%20AND%20SRC:MED&resulttype=core&format=json

Pharmacotherapies for diabetic retinopathy: present and future

15 February 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10792-010-9403-Y

Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10792-010-9403-Y

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

2 references

Crossref

https://api.crossref.org/works/10.1007%2FS10792-010-9403-Y

21 January 2018

12 December 2020

Long-term stability and visual outcome after favorable initial response of proliferative diabetic retinopathy to panretinal photocoagulation

1 reference

12 December 2020

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

1 reference

12 December 2020

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision

1 reference

12 December 2020

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

12 December 2020

Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

1 reference

12 December 2020

Vascular endothelial growth factor is a critical stimulus for diabetic macular edema

1 reference

12 December 2020

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

1 reference

12 December 2020

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

12 December 2020

Evolving guidelines for intravitreous injections

1 reference

12 December 2020

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 reference

12 December 2020

1 reference

12 December 2020